Tilray Brands, Inc. (NASDAQ: TLRY) Stock Competitors & Peer Comparison
See TLRY's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TLRY and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TLRY | $4.66 | -2.41% | 523.4M | -4.32 | -$1.08 | N/A |
| TAK | $17.42 | -0.37% | 55.4B | 12.52 | $1.39 | +3.62% |
| HLN | $9.79 | -1.51% | 43.2B | 18.28 | $0.54 | +1.80% |
| TEVA | $37.04 | +1.54% | 42.8B | 12.54 | $2.93 | N/A |
| VTRS | $16.25 | -0.16% | 18.7B | 6.39 | $2.52 | +2.98% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| ELAN | $22.60 | -0.59% | 11.1B | 20.91 | $1.06 | N/A |
| RDY | $12.42 | -0.24% | 10.3B | 20.30 | $0.61 | +0.67% |
| LNTH | $100.90 | +0.22% | 6.6B | 16.93 | $5.95 | N/A |
Stock Comparison
Takeda Pharmaceutical Company Limited (NYSE: TAK)
TLRY vs TAK Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TAK has a market cap of 55.4B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TAK trades at $17.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TAK's P/E ratio is 12.52. In terms of profitability, TLRY's ROE is -0.08%, compared to TAK's ROE of +0.02%. Regarding short-term risk, TLRY is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check TAK's competition here
Haleon plc (NYSE: HLN)
TLRY vs HLN Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, HLN has a market cap of 43.2B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while HLN trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas HLN's P/E ratio is 18.28. In terms of profitability, TLRY's ROE is -0.08%, compared to HLN's ROE of +0.17%. Regarding short-term risk, TLRY is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check HLN's competition here
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
TLRY vs TEVA Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TEVA has a market cap of 42.8B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TEVA trades at $37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TEVA's P/E ratio is 12.54. In terms of profitability, TLRY's ROE is -0.08%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, TLRY is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check TEVA's competition here
Viatris Inc. (NASDAQ: VTRS)
TLRY vs VTRS Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, VTRS has a market cap of 18.7B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while VTRS trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas VTRS's P/E ratio is 6.39. In terms of profitability, TLRY's ROE is -0.08%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, TLRY is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check VTRS's competition here
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
TLRY vs ITCI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ITCI's P/E ratio is -180.64. In terms of profitability, TLRY's ROE is -0.08%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, TLRY is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ITCI's competition here
Catalent, Inc. (NYSE: CTLT)
TLRY vs CTLT Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CTLT's P/E ratio is -27.84. In terms of profitability, TLRY's ROE is -0.08%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, TLRY is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check CTLT's competition here
Elanco Animal Health Incorporated (NYSE: ELAN)
TLRY vs ELAN Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ELAN has a market cap of 11.1B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ELAN trades at $22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ELAN's P/E ratio is 20.91. In terms of profitability, TLRY's ROE is -0.08%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, TLRY is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ELAN's competition here
Dr. Reddy's Laboratories Limited (NYSE: RDY)
TLRY vs RDY Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, RDY has a market cap of 10.3B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while RDY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas RDY's P/E ratio is 20.30. In terms of profitability, TLRY's ROE is -0.08%, compared to RDY's ROE of +0.09%. Regarding short-term risk, TLRY is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check RDY's competition here
Lantheus Holdings, Inc. (NASDAQ: LNTH)
TLRY vs LNTH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while LNTH trades at $100.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas LNTH's P/E ratio is 16.93. In terms of profitability, TLRY's ROE is -0.08%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, TLRY is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check LNTH's competition here
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
TLRY vs AMRX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, AMRX has a market cap of 5.6B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while AMRX trades at $17.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas AMRX's P/E ratio is 19.62. In terms of profitability, TLRY's ROE is -0.08%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, TLRY is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check AMRX's competition here
Indivior Pharmaceuticals Inc (NASDAQ: INDV)
TLRY vs INDV Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while INDV trades at $38.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas INDV's P/E ratio is 10.61. In terms of profitability, TLRY's ROE is -0.08%, compared to INDV's ROE of -2.16%. Regarding short-term risk, TLRY is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check INDV's competition here
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
TLRY vs SUPN Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SUPN trades at $47.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SUPN's P/E ratio is 15.64. In terms of profitability, TLRY's ROE is -0.08%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, TLRY is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check SUPN's competition here
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
TLRY vs RGC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, RGC has a market cap of 2.5B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while RGC trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas RGC's P/E ratio is -356.34. In terms of profitability, TLRY's ROE is -0.08%, compared to RGC's ROE of -2.32%. Regarding short-term risk, TLRY is more volatile compared to RGC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check RGC's competition here
Bausch Health Companies Inc. (NYSE: BHC)
TLRY vs BHC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while BHC trades at $6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas BHC's P/E ratio is 1.58. In terms of profitability, TLRY's ROE is -0.08%, compared to BHC's ROE of +0.89%. Regarding short-term risk, TLRY is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check BHC's competition here
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
TLRY vs DCPH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas DCPH's P/E ratio is -11.58. In terms of profitability, TLRY's ROE is -0.08%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, TLRY is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check DCPH's competition here
HUTCHMED (China) Limited (NASDAQ: HCM)
TLRY vs HCM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, HCM has a market cap of 2.1B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while HCM trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas HCM's P/E ratio is 4.59. In terms of profitability, TLRY's ROE is -0.08%, compared to HCM's ROE of +0.01%. Regarding short-term risk, TLRY is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check HCM's competition here
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
TLRY vs AVDL Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, TLRY's ROE is -0.08%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, TLRY is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check AVDL's competition here
Embecta Corp. (NASDAQ: EMBCV)
TLRY vs EMBCV Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas EMBCV's P/E ratio is N/A. In terms of profitability, TLRY's ROE is -0.08%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, TLRY is less volatile compared to EMBCV. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check EMBCV's competition here
Dynavax Technologies Corporation (NASDAQ: DVAX)
TLRY vs DVAX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas DVAX's P/E ratio is -41.89. In terms of profitability, TLRY's ROE is -0.08%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, TLRY is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check DVAX's competition here
Perrigo Company plc (NYSE: PRGO)
TLRY vs PRGO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PRGO trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PRGO's P/E ratio is 5.07. In terms of profitability, TLRY's ROE is -0.08%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, TLRY is less volatile compared to PRGO. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check PRGO's competition here
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
TLRY vs ANIP Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ANIP trades at $75.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ANIP's P/E ratio is 9.14. In terms of profitability, TLRY's ROE is -0.08%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, TLRY is more volatile compared to ANIP. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ANIP's competition here
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
TLRY vs TARO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TARO's P/E ratio is 30.05. In terms of profitability, TLRY's ROE is -0.08%, compared to TARO's ROE of +0.03%. Regarding short-term risk, TLRY is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check TARO's competition here
Harrow Health, Inc. (NASDAQ: HROW)
TLRY vs HROW Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while HROW trades at $39.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas HROW's P/E ratio is 437.33. In terms of profitability, TLRY's ROE is -0.08%, compared to HROW's ROE of -1.04%. Regarding short-term risk, TLRY is less volatile compared to HROW. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check HROW's competition here
Phibro Animal Health Corporation (NASDAQ: PAHC)
TLRY vs PAHC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PAHC trades at $34.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PAHC's P/E ratio is 11.54. In terms of profitability, TLRY's ROE is -0.08%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, TLRY is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check PAHC's competition here
Alvotech (NASDAQ: ALVO)
TLRY vs ALVO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ALVO has a market cap of 1.4B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ALVO trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ALVO's P/E ratio is -11.79. In terms of profitability, TLRY's ROE is -0.08%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, TLRY is more volatile compared to ALVO. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ALVO's competition here
Cronos Group Inc. (NASDAQ: CRON)
TLRY vs CRON Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CRON trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CRON's P/E ratio is 30.10. In terms of profitability, TLRY's ROE is -0.08%, compared to CRON's ROE of +0.06%. Regarding short-term risk, TLRY is less volatile compared to CRON. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check CRON's competition here
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
TLRY vs ETON Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ETON has a market cap of 1.1B. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ETON trades at $42.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ETON's P/E ratio is -594.00. In terms of profitability, TLRY's ROE is -0.08%, compared to ETON's ROE of -0.06%. Regarding short-term risk, TLRY is less volatile compared to ETON. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ETON's competition here
Pacira BioSciences, Inc. (NASDAQ: PCRX)
TLRY vs PCRX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PCRX has a market cap of 932.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PCRX trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PCRX's P/E ratio is 9.12. In terms of profitability, TLRY's ROE is -0.08%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, TLRY is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check PCRX's competition here
PetIQ, Inc. (NASDAQ: PETQ)
TLRY vs PETQ Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PETQ's P/E ratio is 83.73. In terms of profitability, TLRY's ROE is -0.08%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, TLRY is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check PETQ's competition here
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
TLRY vs AMPH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, AMPH has a market cap of 881M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while AMPH trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas AMPH's P/E ratio is 6.82. In terms of profitability, TLRY's ROE is -0.08%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, TLRY is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check AMPH's competition here
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
TLRY vs COLL Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, COLL has a market cap of 842.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while COLL trades at $28.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas COLL's P/E ratio is 3.26. In terms of profitability, TLRY's ROE is -0.08%, compared to COLL's ROE of +0.16%. Regarding short-term risk, TLRY is more volatile compared to COLL. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check COLL's competition here
Evotec SE (NASDAQ: EVO)
TLRY vs EVO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, EVO has a market cap of 778M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while EVO trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas EVO's P/E ratio is -3.09. In terms of profitability, TLRY's ROE is -0.08%, compared to EVO's ROE of -0.24%. Regarding short-term risk, TLRY is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check EVO's competition here
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
TLRY vs IRWD Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while IRWD trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas IRWD's P/E ratio is 5.54. In terms of profitability, TLRY's ROE is -0.08%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, TLRY is less volatile compared to IRWD. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check IRWD's competition here
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
TLRY vs BDSI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas BDSI's P/E ratio is 6.82. In terms of profitability, TLRY's ROE is -0.08%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, TLRY is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check BDSI's competition here
Evolus, Inc. (NASDAQ: EOLS)
TLRY vs EOLS Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, EOLS has a market cap of 534.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while EOLS trades at $8.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas EOLS's P/E ratio is -25.71. In terms of profitability, TLRY's ROE is -0.08%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, TLRY is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check EOLS's competition here
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
TLRY vs AQST Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, AQST has a market cap of 530.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while AQST trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas AQST's P/E ratio is -6.93. In terms of profitability, TLRY's ROE is -0.08%, compared to AQST's ROE of +2.44%. Regarding short-term risk, TLRY is less volatile compared to AQST. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check AQST's competition here
Canopy Growth Corporation (NASDAQ: CGC)
TLRY vs CGC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CGC has a market cap of 432.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CGC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CGC's P/E ratio is -0.62. In terms of profitability, TLRY's ROE is -0.08%, compared to CGC's ROE of -0.33%. Regarding short-term risk, TLRY is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check CGC's competition here
Kamada Ltd. (NASDAQ: KMDA)
TLRY vs KMDA Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, KMDA has a market cap of 396.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while KMDA trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas KMDA's P/E ratio is 19.66. In terms of profitability, TLRY's ROE is -0.08%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, TLRY is less volatile compared to KMDA. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check KMDA's competition here
Alpha Teknova, Inc. (NASDAQ: TKNO)
TLRY vs TKNO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TKNO has a market cap of 396.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TKNO trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TKNO's P/E ratio is -23.84. In terms of profitability, TLRY's ROE is -0.08%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, TLRY is less volatile compared to TKNO. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check TKNO's competition here
Alimera Sciences, Inc. (NASDAQ: ALIM)
TLRY vs ALIM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ALIM's P/E ratio is 5.28. In terms of profitability, TLRY's ROE is -0.08%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, TLRY is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ALIM's competition here
Embecta Corp. (NASDAQ: EMBC)
TLRY vs EMBC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, EMBC has a market cap of 281.8M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while EMBC trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas EMBC's P/E ratio is 1.83. In terms of profitability, TLRY's ROE is -0.08%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, TLRY is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check EMBC's competition here
Landec Corporation (NASDAQ: LNDC)
TLRY vs LNDC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas LNDC's P/E ratio is -4.04. In terms of profitability, TLRY's ROE is -0.08%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, TLRY is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check LNDC's competition here
Aurora Cannabis Inc. (NASDAQ: ACB)
TLRY vs ACB Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ACB has a market cap of 236.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ACB trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ACB's P/E ratio is -7.80. In terms of profitability, TLRY's ROE is -0.08%, compared to ACB's ROE of -0.21%. Regarding short-term risk, TLRY is less volatile compared to ACB. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ACB's competition here
Organogenesis Holdings Inc. (NASDAQ: ORGO)
TLRY vs ORGO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ORGO has a market cap of 232.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ORGO trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ORGO's P/E ratio is 60.33. In terms of profitability, TLRY's ROE is -0.08%, compared to ORGO's ROE of -0.24%. Regarding short-term risk, TLRY is less volatile compared to ORGO. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ORGO's competition here
Shineco, Inc. (NASDAQ: TYHT)
TLRY vs TYHT Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TYHT's P/E ratio is -1.61. In terms of profitability, TLRY's ROE is -0.08%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, TLRY is less volatile compared to TYHT. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check TYHT's competition here
SIGA Technologies, Inc. (NASDAQ: SIGA)
TLRY vs SIGA Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SIGA has a market cap of 205.8M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SIGA trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SIGA's P/E ratio is 10.63. In terms of profitability, TLRY's ROE is -0.08%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, TLRY is more volatile compared to SIGA. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check SIGA's competition here
Organigram Global Inc. (NASDAQ: OGI)
TLRY vs OGI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, OGI has a market cap of 181.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while OGI trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas OGI's P/E ratio is -4.96. In terms of profitability, TLRY's ROE is -0.08%, compared to OGI's ROE of -0.07%. Regarding short-term risk, TLRY is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check OGI's competition here
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
TLRY vs LFCR Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, LFCR has a market cap of 178.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while LFCR trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas LFCR's P/E ratio is -4.46. In terms of profitability, TLRY's ROE is -0.08%, compared to LFCR's ROE of -2.51%. Regarding short-term risk, TLRY is more volatile compared to LFCR. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check LFCR's competition here
Recro Pharma, Inc. (NASDAQ: REPH)
TLRY vs REPH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas REPH's P/E ratio is -8.04. In terms of profitability, TLRY's ROE is -0.08%, compared to REPH's ROE of -0.22%. Regarding short-term risk, TLRY is less volatile compared to REPH. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check REPH's competition here
Journey Medical Corporation (NASDAQ: DERM)
TLRY vs DERM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, DERM has a market cap of 177M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while DERM trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas DERM's P/E ratio is -17.38. In terms of profitability, TLRY's ROE is -0.08%, compared to DERM's ROE of -0.36%. Regarding short-term risk, TLRY is less volatile compared to DERM. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check DERM's competition here
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
TLRY vs CRDL Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CRDL has a market cap of 175.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CRDL trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CRDL's P/E ratio is -5.41. In terms of profitability, TLRY's ROE is -0.08%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, TLRY is less volatile compared to CRDL. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check CRDL's competition here
Theratechnologies Inc. (NASDAQ: THTX)
TLRY vs THTX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas THTX's P/E ratio is -28.83. In terms of profitability, TLRY's ROE is -0.08%, compared to THTX's ROE of +0.17%. Regarding short-term risk, TLRY is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check THTX's competition here
Assertio Holdings, Inc. (NASDAQ: ASRT)
TLRY vs ASRT Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ASRT trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ASRT's P/E ratio is -7.10. In terms of profitability, TLRY's ROE is -0.08%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, TLRY is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ASRT's competition here
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
TLRY vs CPIX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CPIX has a market cap of 119.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CPIX trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CPIX's P/E ratio is -19.90. In terms of profitability, TLRY's ROE is -0.08%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, TLRY is less volatile compared to CPIX. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check CPIX's competition here
Societal CDMO, Inc. (NASDAQ: SCTL)
TLRY vs SCTL Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SCTL's P/E ratio is -7.86. In terms of profitability, TLRY's ROE is -0.08%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, TLRY is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check SCTL's competition here
BGM Group Ltd. (NASDAQ: BGM)
TLRY vs BGM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, BGM has a market cap of 111.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while BGM trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas BGM's P/E ratio is -1.01. In terms of profitability, TLRY's ROE is -0.08%, compared to BGM's ROE of -0.07%. Regarding short-term risk, TLRY is less volatile compared to BGM. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check BGM's competition here
Procaps Group S.A. (NASDAQ: PROC)
TLRY vs PROC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PROC's P/E ratio is 1.53. In terms of profitability, TLRY's ROE is -0.08%, compared to PROC's ROE of -2.22%. Regarding short-term risk, TLRY is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check PROC's competition here
OptiNose, Inc. (NASDAQ: OPTN)
TLRY vs OPTN Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas OPTN's P/E ratio is -4.42. In terms of profitability, TLRY's ROE is -0.08%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, TLRY is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check OPTN's competition here
Zomedica Corp. (AMEX: ZOM)
TLRY vs ZOM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ZOM's P/E ratio is -1.62. In terms of profitability, TLRY's ROE is -0.08%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, TLRY is less volatile compared to ZOM. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ZOM's competition here
Upexi, Inc. (NASDAQ: GRVI)
TLRY vs GRVI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas GRVI's P/E ratio is 26.05. In terms of profitability, TLRY's ROE is -0.08%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, TLRY is less volatile compared to GRVI. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check GRVI's competition here
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
TLRY vs ZYBT Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ZYBT has a market cap of 73.5M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ZYBT trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ZYBT's P/E ratio is -7.05. In terms of profitability, TLRY's ROE is -0.08%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, TLRY is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ZYBT's competition here
Talphera, Inc. (NASDAQ: TLPH)
TLRY vs TLPH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TLPH has a market cap of 72.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TLPH trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TLPH's P/E ratio is -4.52. In terms of profitability, TLRY's ROE is -0.08%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, TLRY is less volatile compared to TLPH. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check TLPH's competition here
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
TLRY vs ZYNE Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, TLRY's ROE is -0.08%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, TLRY is less volatile compared to ZYNE. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ZYNE's competition here
Silver Spike Investment Corp. (NASDAQ: SSIC)
TLRY vs SSIC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SSIC's P/E ratio is 11.93. In terms of profitability, TLRY's ROE is -0.08%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, TLRY is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check SSIC's competition here
The Valens Company Inc. (NASDAQ: VLNS)
TLRY vs VLNS Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas VLNS's P/E ratio is -1.03. In terms of profitability, TLRY's ROE is -0.08%, compared to VLNS's ROE of N/A. Regarding short-term risk, TLRY is similarly volatile compared to VLNS. This indicates similar risk in terms of short-term price fluctuations for TLRY.Check VLNS's competition here
DURECT Corporation (NASDAQ: DRRX)
TLRY vs DRRX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas DRRX's P/E ratio is -4.44. In terms of profitability, TLRY's ROE is -0.08%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, TLRY is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check DRRX's competition here
InterCure Ltd. (NASDAQ: INCR)
TLRY vs INCR Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, INCR has a market cap of 57.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while INCR trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas INCR's P/E ratio is -2.23. In terms of profitability, TLRY's ROE is -0.08%, compared to INCR's ROE of -0.09%. Regarding short-term risk, TLRY is less volatile compared to INCR. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check INCR's competition here
Jupiter Wellness, Inc. (NASDAQ: JUPW)
TLRY vs JUPW Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas JUPW's P/E ratio is -2.41. In terms of profitability, TLRY's ROE is -0.08%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, TLRY is less volatile compared to JUPW. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check JUPW's competition here
China Pharma Holdings, Inc. (AMEX: CPHI)
TLRY vs CPHI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CPHI has a market cap of 44.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CPHI trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CPHI's P/E ratio is -1.72. In terms of profitability, TLRY's ROE is -0.08%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, TLRY is less volatile compared to CPHI. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check CPHI's competition here
Qilian International Holding Group Limited (NASDAQ: QLI)
TLRY vs QLI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas QLI's P/E ratio is -4.92. In terms of profitability, TLRY's ROE is -0.08%, compared to QLI's ROE of -0.16%. Regarding short-term risk, TLRY is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check QLI's competition here
HEXO Corp. (NASDAQ: HEXO)
TLRY vs HEXO Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas HEXO's P/E ratio is -0.26. In terms of profitability, TLRY's ROE is -0.08%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, TLRY is less volatile compared to HEXO. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check HEXO's competition here
Rockwell Medical, Inc. (NASDAQ: RMTI)
TLRY vs RMTI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, RMTI has a market cap of 30.8M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while RMTI trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas RMTI's P/E ratio is -7.42. In terms of profitability, TLRY's ROE is -0.08%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, TLRY is less volatile compared to RMTI. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check RMTI's competition here
Aytu BioPharma, Inc. (NASDAQ: AYTU)
TLRY vs AYTU Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while AYTU trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas AYTU's P/E ratio is -1.23. In terms of profitability, TLRY's ROE is -0.08%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, TLRY is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check AYTU's competition here
TherapeuticsMD, Inc. (NASDAQ: TXMD)
TLRY vs TXMD Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, TXMD has a market cap of 24.1M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while TXMD trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas TXMD's P/E ratio is 105.96. In terms of profitability, TLRY's ROE is -0.08%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, TLRY is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check TXMD's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)
TLRY vs CYTH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CYTH's P/E ratio is -0.80. In terms of profitability, TLRY's ROE is -0.08%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, TLRY is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check CYTH's competition here
Evoke Pharma, Inc. (NASDAQ: EVOK)
TLRY vs EVOK Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas EVOK's P/E ratio is -7.97. In terms of profitability, TLRY's ROE is -0.08%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, TLRY is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check EVOK's competition here
Optimi Health Corp. (NASDAQ: OPTH)
TLRY vs OPTH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, OPTH has a market cap of 15.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while OPTH trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas OPTH's P/E ratio is -17.38. In terms of profitability, TLRY's ROE is -0.08%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, TLRY is less volatile compared to OPTH. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check OPTH's competition here
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
TLRY vs ACRX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ACRX's P/E ratio is -0.31. In terms of profitability, TLRY's ROE is -0.08%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, TLRY is less volatile compared to ACRX. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ACRX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
TLRY vs BFRIW Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, BFRIW has a market cap of 13.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while BFRIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, TLRY's ROE is -0.08%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, TLRY is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
TLRY vs COSM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, COSM has a market cap of 11.7M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while COSM trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas COSM's P/E ratio is -0.29. In terms of profitability, TLRY's ROE is -0.08%, compared to COSM's ROE of -0.96%. Regarding short-term risk, TLRY is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check COSM's competition here
Agile Therapeutics, Inc. (NASDAQ: AGRX)
TLRY vs AGRX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas AGRX's P/E ratio is -0.89. In terms of profitability, TLRY's ROE is -0.08%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, TLRY is less volatile compared to AGRX. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check AGRX's competition here
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
TLRY vs NLTX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas NLTX's P/E ratio is -0.28. In terms of profitability, TLRY's ROE is -0.08%, compared to NLTX's ROE of -0.45%. Regarding short-term risk, TLRY is less volatile compared to NLTX. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check NLTX's competition here
Lannett Company, Inc. (NYSE: LCI)
TLRY vs LCI Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas LCI's P/E ratio is -0.04. In terms of profitability, TLRY's ROE is -0.08%, compared to LCI's ROE of +1.66%. Regarding short-term risk, TLRY is less volatile compared to LCI. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check LCI's competition here
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
TLRY vs ADMP Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ADMP's P/E ratio is -0.08. In terms of profitability, TLRY's ROE is -0.08%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, TLRY is less volatile compared to ADMP. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check ADMP's competition here
cbdMD, Inc. (AMEX: YCBD)
TLRY vs YCBD Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, YCBD has a market cap of 6.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while YCBD trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas YCBD's P/E ratio is -1.49. In terms of profitability, TLRY's ROE is -0.08%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, TLRY is less volatile compared to YCBD. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check YCBD's competition here
Gelteq Limited Ordinary Shares (NASDAQ: GELS)
TLRY vs GELS Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, GELS has a market cap of 5.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while GELS trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas GELS's P/E ratio is -1.14. In terms of profitability, TLRY's ROE is -0.08%, compared to GELS's ROE of -0.25%. Regarding short-term risk, TLRY is more volatile compared to GELS. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check GELS's competition here
Mallinckrodt plc (AMEX: MNK)
TLRY vs MNK Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas MNK's P/E ratio is -0.44. In terms of profitability, TLRY's ROE is -0.08%, compared to MNK's ROE of -0.36%. Regarding short-term risk, TLRY is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check MNK's competition here
Flora Growth Corp. (NASDAQ: FLGC)
TLRY vs FLGC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas FLGC's P/E ratio is -0.19. In terms of profitability, TLRY's ROE is -0.08%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, TLRY is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check FLGC's competition here
Universe Pharmaceuticals Inc. (NASDAQ: UPC)
TLRY vs UPC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, UPC has a market cap of 3.8M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while UPC trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas UPC's P/E ratio is -0.75. In terms of profitability, TLRY's ROE is -0.08%, compared to UPC's ROE of -0.03%. Regarding short-term risk, TLRY is less volatile compared to UPC. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check UPC's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
TLRY vs SBFM Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SBFM trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SBFM's P/E ratio is -0.20. In terms of profitability, TLRY's ROE is -0.08%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, TLRY is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check SBFM's competition here
PLx Pharma Inc. (NASDAQ: PLXP)
TLRY vs PLXP Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PLXP's P/E ratio is -0.22. In terms of profitability, TLRY's ROE is -0.08%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, TLRY is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check PLXP's competition here
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH)
TLRY vs SHPH Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SHPH has a market cap of 2.5M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SHPH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SHPH's P/E ratio is -0.20. In terms of profitability, TLRY's ROE is -0.08%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, TLRY is less volatile compared to SHPH. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check SHPH's competition here
Athenex, Inc. (NASDAQ: ATNX)
TLRY vs ATNX Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas ATNX's P/E ratio is -0.02. In terms of profitability, TLRY's ROE is -0.08%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, TLRY is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check ATNX's competition here
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
TLRY vs SNOA Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SNOA has a market cap of 2.3M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SNOA trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SNOA's P/E ratio is -1.16. In terms of profitability, TLRY's ROE is -0.08%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, TLRY is less volatile compared to SNOA. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check SNOA's competition here
Procaps Group, S.A. (NASDAQ: PROCW)
TLRY vs PROCW Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while PROCW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas PROCW's P/E ratio is N/A. In terms of profitability, TLRY's ROE is -0.08%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, TLRY is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check PROCW's competition here
RedHill Biopharma Ltd. (NASDAQ: RDHL)
TLRY vs RDHL Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while RDHL trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas RDHL's P/E ratio is 0.12. In terms of profitability, TLRY's ROE is -0.08%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, TLRY is less volatile compared to RDHL. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check RDHL's competition here
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
TLRY vs SXTC Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, SXTC has a market cap of 1.8M. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while SXTC trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas SXTC's P/E ratio is 1.18. In terms of profitability, TLRY's ROE is -0.08%, compared to SXTC's ROE of -0.31%. Regarding short-term risk, TLRY is less volatile compared to SXTC. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check SXTC's competition here
cbdMD, Inc. (AMEX: YCBD-PA)
TLRY vs YCBD-PA Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, YCBD-PA has a market cap of 928.2K. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while YCBD-PA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas YCBD-PA's P/E ratio is -2.69. In terms of profitability, TLRY's ROE is -0.08%, compared to YCBD-PA's ROE of -0.34%. Regarding short-term risk, TLRY is less volatile compared to YCBD-PA. This indicates lower risk in terms of short-term price fluctuations for TLRY.Check YCBD-PA's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTHW)
TLRY vs CYTHW Comparison August 2026
Tilray Brands, Inc. (NASDAQ: TLRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLRY stands at 523.4M. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, TLRY is priced at $4.66 on the NASDAQ, while CYTHW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLRY currently has a P/E ratio of -4.32, whereas CYTHW's P/E ratio is N/A. In terms of profitability, TLRY's ROE is -0.08%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, TLRY is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for TLRY.Check CYTHW's competition here